88 related articles for article (PubMed ID: 3969692)
1. [Effect of antineoplastic agents and ionizing radiation on a human testicular cancer heterograft].
Osieka R; Bamberg M; Pfeiffer R; Glatte P; Scherer E; Schmidt CG
Strahlentherapie; 1985 Jan; 161(1):35-46. PubMed ID: 3969692
[TBL] [Abstract][Full Text] [Related]
2. [Anti-cancer drug sensitivity test against human testicular cancer xenograft--comparison with clinical results of chemotherapy].
Miki T; Kotake T
Hinyokika Kiyo; 1988 Nov; 34(11):1903-9. PubMed ID: 3242364
[TBL] [Abstract][Full Text] [Related]
3. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
[TBL] [Abstract][Full Text] [Related]
4. Human malignant melanoma: preclinical and clinical drug evaluation.
Osieka R
Behring Inst Mitt; 1984 May; (74):353-67. PubMed ID: 6383327
[TBL] [Abstract][Full Text] [Related]
5. [Application to chemosensitivity tests of the human tumor-nude mouse system and subrenal capsule assay system].
Fujita M; Fujita F; Shimozuma K; Sakamoto Y; Kusuyama T; Usugane M; Origasa H; Taguchi T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1227-34. PubMed ID: 3729446
[TBL] [Abstract][Full Text] [Related]
6. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
[TBL] [Abstract][Full Text] [Related]
7. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
Schlappack OK; Bush C; Delic JI; Steel GG
Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
[No Abstract] [Full Text] [Related]
8. [Comparison of a continuous infusion with a daily bolus injection of bleomycin in a heterotransplanted human testicular cancer].
Osieka R
Arzneimittelforschung; 1984; 34(4):460-4. PubMed ID: 6204651
[TBL] [Abstract][Full Text] [Related]
9. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
10. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
12. [High-dose chemotherapy with autologous bone marrow transplantation or peripheral blood stem cell transplantation--testicular cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1771-6. PubMed ID: 7574808
[TBL] [Abstract][Full Text] [Related]
13. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
14. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
15. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion versus intermittent bolus injection of bleomycin in a human embryonal testicular cancer xenograft.
Osieka R; Glatte P; Schmidt CG
Cancer Treat Rep; 1984 May; 68(5):799-801. PubMed ID: 6202408
[TBL] [Abstract][Full Text] [Related]
17. Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).
Winograd B; Boven E; Lobbezoo MW; Pinedo HM
In Vivo; 1987; 1(1):1-13. PubMed ID: 2979758
[TBL] [Abstract][Full Text] [Related]
18. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
19. [Application of nude mouse-human cancer xenograft system for sensitivity test of anticancer drugs].
Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1982 Apr; 9(4):606-15. PubMed ID: 7184418
[TBL] [Abstract][Full Text] [Related]
20. Resection of retroperitoneal residual tumor after chemotherapy for testicular cancer indication and surgical techniques.
Albers P
Crit Rev Oncol Hematol; 2004 Apr; 50(1):79-85. PubMed ID: 15094161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
